Side-by-side comparison of AI visibility scores, market position, and capabilities
Rightway is the most transparent PBM and care navigation platform for employers; delivers 16.1% lower pharmacy costs and 15% medical cost savings; launched 2025 rebrand as integrated PBM + care navigation leader.
Rightway is a healthcare benefits company that combines Pharmacy Benefits Management (PBM) and personalized care navigation in a single integrated platform for self-insured employers. Founded in 2017 and headquartered in New York City, Rightway positions itself as the most transparent and member-focused PBM in the market — operating on fully aligned, pass-through pricing with a 100% transparency model and a total pharmacy spend guarantee that traditional PBMs do not offer. The company launched a significant 2025 rebrand marking its evolution from challenger to category leader.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.